+147.0%
MRNA vs ALLY
+45.3%
+101.7%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | ALLY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.7% | -0.5% | -1.4% |
| 7D | -12.7% | -5.2% | -7.5% | -10.6% |
| 30D | -20.7% | -5.3% | -15.4% | -18.7% |
| 3M | +46.3% | -13.3% | +59.6% | +55.8% |
| 6M | +305.2% | -13.4% | +318.6% | +330.3% |
| YTD | +561.2% | -17.4% | +578.6% | +616.2% |
| 1Y | +772.1% | -0.4% | +772.5% | +761.5% |
| 3Y | +147.0% | +44.4% | +102.6% | +111.3% |
| All | +147.0% | +45.3% | +101.7% | +111.3% |
Cumulative growth
Daily Returns
Daily percentage return beside ALLY.
Daily Out/Under-Performance
Portfolio return minus ALLY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALLY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded ALLY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling